Nav: Home

Ebola: Lives to be saved with new management approach

May 15, 2017

  • Ebola outbreaks set to be managed quickly and efficiently - saving lives - with a new approach developed by an international team of researchers, including the University of Warwick

  • Educating people in areas affected by Ebola about how the disease spreads through communities is consistently the most effective strategy for halting an epidemic

  • Lots of intervention models created during 2014 Ebola outbreak - researchers re-assessed 37 models to calculate optimal strategy

  • 2014 Ebola epidemic resulted in 28,646 cases, and claimed 11,323 lives by March 2016 - using this approach with same numbers would create a reduction of 3266 cases, and save 1633 lives

Ebola outbreaks are set to be managed quickly and efficiently - saving lives - with a new approach developed by an international team of researchers, including the University of Warwick, which helps to streamline outbreak decision-making.

Dr Michael Tildesley from the School of Life Sciences - with researchers from Penn State University in the USA - have discovered that educating people in areas affected by Ebola about how the disease spreads through communities is the most effective strategy for halting an epidemic.

During the 2014 Ebola outbreak, numerous different intervention models were created with the aim of finding the best strategy to stop the spread of the disease.

The researchers re-assessed thirty-seven of these models and simulated many different outbreak scenarios using varying methods - including increased hospitalisation and community education about disease transmission - to identify the most consistent approach to tackling Ebola infections.

Of all the models that the research team evaluated, the majority consistently ranked two commonly proposed management strategies as the most effective: reducing transmission rates at funerals and reducing transmission rates in the community.

For example, by ensuring safe burials, reducing risky behaviour, providing household sanitation kits, encouraging sick individuals to remain at home, and increased community awareness.

Strategies which focused on reducing transmission at hospitals and increasing hospitalisation rates, however, were not well ranked.

At the start of the 2014 outbreak, there was confusion caused by lots of different predictions about how many cases there would be. But these differences may distract from the ultimate goal of limiting the outbreak.

This new approach identifies consistent patterns in projections and means that future outbreaks can be efficiently managed by policy-makers, and research efforts prioritised - to save more lives.

The 2014 Ebola epidemic resulted in 28,646 cases, and claimed 11,323 lives by March 2016. If a future Ebola epidemic had exactly the same numbers, using this approach could create a reduction of 3266 cases, and save 1633 lives.

Dr Tildesley commented: "When a disease outbreak happens, there is a lot of uncertainty regarding how the epidemic is going to spread in the future. However, we can't afford to wait before implementing control - we need to make rapid decisions in the face of this uncertainty.

"Our approach allows us to make best use of the information that is available and to manage an outbreak in the most effective way, thus saving lives."

Shou-Li Li, postdoctoral researcher at Penn State and first author of the study, commented:

"Our approach synthesizes data from many models and provides two important pieces of information. It identifies the best course of action, given what we know now, and highlights the gaps in our knowledge that actually matter to the selection of interventions strategies.

"It could guide the management of outbreaks where rapid decision-making is critical, including diseases we know a lot about, like influenza, those that we don't know a lot about, like Zika, and those that we don't even know exist.

"The difference between the projections and the actual size of the 2014 Ebola outbreak caused intense public debate. But rather than focusing on how big the outbreak would be, our study focused on what to do to keep it small?"
-end-
The paper, 'Essential information: Uncertainty and optimal control of Ebola outbreaks', is published in the Proceedings of the National Academy of Sciences.

The research team at Penn State includes Shou-Li Li, Katriona Shea, Ottar Bjørnstad, Matthew Ferrari and undergraduate Riley Mummah.

This research was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) in the UK, as well as the National Science Foundation and National Institute of Health in the USA, with support from the Huck Institutes of the Life Sciences.

Also collaborating on the paper were William Probert from the University of Warwick, Michael Runge from the USGS Patuxent Wildlife Research Center, and Christopher Fonnesbeck from Vanderbilt University School of Medicine.

University of Warwick

Related Ebola Articles:

Ebola survivors have a 'unique' retinal scar
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.
Ebola: Lives to be saved with new management approach
Ebola outbreaks are set to be managed quickly and efficiently -- saving lives -- with a new approach developed by an international team of researchers, including the University of Warwick, which helps to streamline outbreak decision-making.
Ebola vaccines provide immune responses after 1 year
Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.
New scoring system predicts Ebola severity
While Ebola virus disease (EVD) is notorious for being one of the world's most deadly infections, it actually has a wide range of outcomes, where asymptomatic presentation may be as common as fatality.
Could co-infection with other viruses affect the survival of those with Ebola virus?
Could co-infection with other viruses have a detrimental affect on Ebola survival, and why did some show Ebola symptoms without having the virus?
Antimalarial being tested as possible Ebola virus drug
The National Center for Advancing Translational Sciences (NCATS) recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc.
Ebola map may help prepare for future outbreaks
To be prepared for new Ebola virus disease cases, it is fundamental to start by identifying the range of the virus and the regions that are more favorable for its propagation.
Sexual transmission of Ebola likely to impact course of outbreaks
Sexual transmission of the Ebola virus could have a major impact on the dynamics of the disease, potentially reigniting an outbreak that has been contained by public health interventions, according to research by University of Georgia ecologists just published in the Royal Society journal Biology Letters.
Ebola vaccine: Promising phase I trials
The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe.
Improving treatments for post-Ebola syndrome sufferers
Researchers from the University of Liverpool and the King's Sierra Leone Partnership are to present new findings into post-Ebola syndrome at a major European conference this week.

Related Ebola Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".